
The Man Studying Your Blood Sugar #686
From Biohacking News by Zestology by Tony Wrighton
April 2, 2026 · 6 min · Episode 688
About this episode
Sharam Fouladgar-Mercer discusses the impact of running Signos and analyzing data from a large clinical trial on his personal health routine.
Biohackers have been using CGMs (Continuous Glucose Monitors) for years. Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared CGM for weight management. So how has running a company (and looking at all the data from their 35k person clinical trial) changed his own routine? Follow Sharam Fouladgar-Mercer on LinkedIn.
People in this episode
Host: Tony Wrighton
Guest: Sharam Fouladgar-Mercer
Topics covered
- Continuous Glucose Monitors
- weight management
- biohacking
- health data
- clinical trials
Keywords
- CGM
- blood sugar
- biohacking
- health
- nutrition
- weight management
- clinical trial
Mentioned in this episode
Organizations: Signos, FDA
More episodes of Biohacking News by Zestology
- Liposomal Vitamins, Liver & What's Living In Your Dust? #705 · June 11, 2026 · 10 min
- Is Mold Making You Sick? (Feat. Alex Manos) #704 · June 8, 2026 · 35 min
- What's the ultimate daily routine for health, recovery and peak performance? #703 · June 4, 2026 · 6 min
- Beyond Biohacking Review + New Oura Ring + Enhanced Games (feat. Dr. Richard L. Blake) #702 · June 1, 2026 · 34 min
- The Big Burnout Warning Sign (Clue: It Happens at 4am) #701 · May 28, 2026 · 6 min
- The One Rule Every Elite Athlete Follows - That You're Probably Ignoring (feat. Elizabeth Svoboda) #700 · May 25, 2026 · 30 min
Explore listener stats, chart rankings, contacts and more on the Biohacking News by Zestology podcast page.